Human monoclonal antibodies against human IL-4

Details for Australian Patent Application No. 2005268932 (hide)

Owner Novartis AG.

Inventors Carballido Herrera, Jose M.; Schwaerzler, Christoph; De Vries, Jan E.

Agent Davies Collison Cave

Pub. Number AU-B-2005268932

PCT Pub. Number WO2006/013087

Priority 0417303.5 03.08.04 GB; 0417301.9 03.08.04 GB; 0417302.7 03.08.04 GB; 0417305.0 03.08.04 GB; 0417306.8 03.08.04 GB; 0417304.3 03.08.04 GB

Filing date 2 August 2005

Wipo publication date 9 February 2006

Acceptance publication date 25 June 2009

International Classifications

C07K 16/24 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

15 February 2007 PCT application entered the National Phase

  PCT publication WO2006/013087 Priority application(s): WO2006/013087

25 June 2009 Application Accepted

  Published as AU-B-2005268932

22 October 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005268943-Preparation of organisms with faster growth and/or higher yield

2005268929-Phenytoin formulations, and uses thereof in wound healing